The economic burden of stroke care in England, Wales and Northern Ireland: Using a national stroke register to estimate and report patient-level health economic outcomes in stroke

European Stroke Journal

Volumn 3, Issue 1, 2018, Pages 82-91

  Xu, Xiang Ming ^a   Vestesson, Emma ^a   Paley, Lizz ^a   Desikan, Anita ^b   Wonderling, David ^a   Hoffman, Alex ^a   Wolfe, Charles D A ^b   Rudd, Anthony G ^b   Bray, Benjamin D ^c  

^a ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cost; health economics; registers; stroke

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DISEASE SEVERITY; ENGLAND; HEALTH CARE ACCESS; HEALTH CARE COST; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MECHANICAL THROMBECTOMY; NORTHERN IRELAND; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL CARE; WALES;

EID: 85058794662     PISSN: 23969873     EISSN: 23969881     Source Type: Journal    
DOI: 10.1177/2396987317746516     Document Type: Article

References (23)

1. Feigin VL, Krishnamurthi RV, Parmar P, GBD 2013 Writing Group.; GBD 2013 Stroke Panel Experts Group. Update on the global burden of ischemic and hemorrhagic stroke in 1990-2013: the GBD 2013 study. Neuroepidemiology 2015; 45: 161–176.
2. Newton JN, Briggs AD, Murray CJ, Changes in health in England, with analysis by English regions and areas of deprivation, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386: 2257–2274.
3. Evers SM, Struijs JN, Ament AJ, International comparison of stroke cost studies. Stroke 2004; 35: 1209–1215.
4. Saka O, McGuire A, Wolfe C. Cost of stroke in the United Kingdom. Age Ageing 2009; 38: 27–32.
5. Whittington JW, Nolan K, Lewis N, Pursuing the triple aim: the first 7 years. Milbank Q 2015; 93: 263–300.
6. Porter ME. What is value in health care? N Engl J Med 2010; 363: 2477–2481.
7. Johnsen SP, Ingeman A, Hundborg HH, The Danish Stroke Registry. Clin Epidemiol 2016; 8: 697–702.
8. Fonarow GC, Reeves MJ, Smith EE, GWTG-Stroke Steering Committee and Investigators. Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines – stroke. Circ Cardiovasc Qual Outcomes 2010; 3: 291–230.
9. Asplund K, Hulter Åsberg K, Appelros P, The Riks-Stroke story: building a sustainable national register for quality assessment of stroke care. Int J Stroke 2011; 6: 99–108.
10. Sentinel Stroke National Audit Programme, www.strokeaudit.org. (accessed 23 May 2017)
11. Brennan A, Chick SE, Davies R. A taxonomy of model structures for economic evaluation of health technologies. Health Econ 2006; 15: 1295–1310.
12. Whynes DK, Sprigg N, Selby J, Investigators ENOS. Testing for differential item functioning within the EQ-5D. Med Decis Making 2013; 33: 252–260.
13. Wolfe CD, Crichton SL, Heuschmann PU, Estimates of outcomes up to ten years after stroke: analysis from the prospective South London Stroke Register. PLoS Med 2011; 8: e1001033.
14. Wardlaw JM, Murray V, Berge E, Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2014; 7: CD000213.
15. Early Supported Discharge Trialists. Services for reducing duration of hospital care for acute stroke patients. Cochrane Database Syst Rev 2005; 2: CD000443.
16. van Eeden M, van Heugten C, van Mastrigt GA, The burden of stroke in the Netherlands: estimating quality of life and costs for 1 year poststroke. BMJ Open 2025; 5: e008220.
17. Persson J, Ferraz-Nunes J, Karlberg I. Economic burden of stroke in a large county in Sweden. BMC Health Serv Res 2012; 12: 341.
18. National Audit Office, Progress in improving stroke care. Report on the findings from our modelling of stroke care provision, www.nao.org.uk/report/department-of-health-progress-in-improving-stroke-care (2010, accessed 23 May 2017)
19. Nelson EC, Dixon-Woods M, Batalden PB, Patient focused registries can improve health, care, and science. BMJ 2016; 354: i3319.
20. Sterne JA, Bodalia PN, Bryden PA, Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis. Health Technol Assess 2017; 21: 1–386.
21. Lauer MS, D'Agostino RB, Sr. The randomized registry trial – the next disruptive technology in clinical research? N Engl J Med 2013; 369: 1579–1581.
22. Demaerschalk BM, Hwang HM, Leung G. US cost burden of ischemic stroke: a systematic literature review. Am J Manag Care 2010; 16: 525–533.
23. Aronsson M, Persson J, Blomstrand C, Cost-effectiveness of endovascular thrombectomy in patients with acute ischemic stroke. Neurology 2016; 86: 1053–1059.